Ni, Kaiyuan http://orcid.org/0000-0002-8152-6746
Xu, Ziwan
Culbert, August
Luo, Taokun http://orcid.org/0000-0001-5894-0490
Guo, Nining http://orcid.org/0000-0001-7493-2079
Yang, Kaiting
Pearson, Erik
Preusser, Ben
Wu, Tong http://orcid.org/0000-0001-9968-9909
La Riviere, Patrick
Weichselbaum, Ralph R.
Spiotto, Michael T.
Lin, Wenbin http://orcid.org/0000-0001-7035-7759
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (U01–CA198989, 1R01CA253655)
U.S. Department of Defense (PC170934P2)
Article History
Received: 19 May 2020
Accepted: 12 January 2022
First Online: 21 February 2022
Change Date: 11 November 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41551-022-00966-3
Competing interests
: W.L. is founder of Coordination Pharmaceuticals, which licensed the nMOF technology from the University of Chicago. R.R.W. is a consultant to Coordination Pharmaceuticals. The other authors declare no competing interests.